These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7795731)

  • 1. Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis.
    Yoshii Y; Saito A; Tsuboi K; Tsurushima H; Komatsu Y; Tomono Y; Hyodo A; Nose T
    Noshuyo Byori; 1995 Mar; 12(1):61-7. PubMed ID: 7795731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry and DNA densitometry of human gliomas by image analysis.
    Yoshii Y; Saito A; Nose T
    J Neurooncol; 1995 Oct; 26(1):1-9. PubMed ID: 8583239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image analysis of nuclear DNA content and morphometric characteristics of the tumor cells in human astrocytomas.
    Saito A; Yoshii Y; Nose T
    Noshuyo Byori; 1994; 11(2):143-6. PubMed ID: 7894615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
    Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco CM; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
    Basic Appl Histochem; 1986; 30(2):175-80. PubMed ID: 3741314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flow cytometric studies of human brain tumors. Part I: Human malignant brain tumors (author's transl)].
    Kawamoto K; Nishiyama T; Ikeda Y; Yamanouchi Y; Kawamura Y; Matsumura H; Hirano A; Herz F; Wolley RC
    No Shinkei Geka; 1980 Aug; 8(8):723-8. PubMed ID: 6999372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy status and DNA content instability within single tumors in renal cell carcinoma.
    Bringuier PP; Bouvier R; Berger N; Piaton E; Revillard JP; Perrin P; Devonec M
    Cytometry; 1993; 14(5):559-64. PubMed ID: 8354129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ploidy and nuclear morphometry in adult intracranial ependymomas.
    Onguru O; Ulutin C; Celasun B; Gunhan O
    Clin Neuropathol; 2003; 22(6):266-72. PubMed ID: 14672504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between DNA ploidy level and tumor sociology behavior in 12 nervous cell lines.
    Kiss R; Camby I; Salmon I; Van Ham P; Brotchi J; Pasteels JL
    Cytometry; 1995 Jun; 20(2):118-26. PubMed ID: 7664622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of nuclear size, ploidy, DNA histogram type and proliferation index in 79 nerve sheath tumors.
    Salmon I; Kiss R; Segers V; Carroyer JM; Levivier M; Pasteels JL; Brotchi J; Flament-Durand J
    Anticancer Res; 1992; 12(6B):2277-83. PubMed ID: 1295475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy study in oral carcinomas: use of improved methodology to assess its clinical prognostic value.
    Brandizzi D; Lanfranchi HE; Cabrini RL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):406-12. PubMed ID: 19716508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
    Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
    Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables.
    Kildal W; Kaern J; Kraggerud SM; Abeler VM; Sudbø J; Tropè CG; Lothe RA; Danielsen HE
    Cancer Genet Cytogenet; 2004 Nov; 155(1):25-32. PubMed ID: 15527899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation.
    Danque PO; Chen HB; Patil J; Jagirdar J; Orsatti G; Paronetto F
    Mod Pathol; 1993 May; 6(3):270-5. PubMed ID: 8346174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma.
    Ruiz-Cerdá JL; Hernández M; Gomis F; Vera CD; Kimler BF; O'Connor JE; Jiménez-Cruz F
    J Urol; 1996 Feb; 155(2):459-65. PubMed ID: 8558635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.